Complex Reconstruction After Sarcoma Resection and the Role of the Plastic Surgeon A Case Series of 298 Patients Treated at a Single Center

被引:7
作者
Leckenby, Jonathan I. [1 ]
Deegan, Rachel [2 ]
Grobbelaar, Adriaan O. [1 ]
机构
[1] Royal Free Fdn Trust, Dept Plast & Reconstruct Surg, London NW3 2QG, England
[2] Royal Natl Orthopaed Hosp, Stanmore, Middx, England
关键词
sarcoma; reconstructive surgery; plastic surgery; microsurgery; LYMPH-NODE BIOPSY; INDOCYANINE GREEN FLUORESCENCE; TERM-FOLLOW-UP; CUTANEOUS MELANOMA; ANASTOMOTIC PERFUSION; CLINICAL-TRIAL; NECK MELANOMA; SKIN-CANCER; SENTINEL; SURVIVAL;
D O I
10.1097/SAP.0000000000001190
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: More than 1000 new patients present to the London Sarcoma Unit each year and between 5% and 10% require plastic surgery intervention. Advancements in radiotherapy and chemotherapy protocols combined with higher expectations for limb preservation has led to increased reconstructive challenges. Frequently, primary closure is achievable; however, larger tumors often require specialist reconstruction. Study Design: Aretrospective chart reviewof all referred patients fromthe London Sarcoma Unit requiring reconstruction between February 2006 and January 2015 was performed. Patients who underwent primary amputation were excluded. Results: The total number of operations performed was 298 and the mean follow-up was 16 months (12-46 months). 51% of patients had major comorbidities. Patients could be separated into early (0-1 week postoperatively, n = 167) and late reconstructions (> 1 week postoperatively, n = 131). 32 patients were reconstructed with skin grafts, 137 patients were managed with regional flaps and 129 patients were treated with free flaps. Conclusions: A patient with 3 or more major comorbidities resulted in a significantly increased risk of reconstructive failure (P < 0.05). Our experience has lead us to adhere to the following guidelines: (1) All patients should be reviewed in a multidisciplinary team meeting. (2) After primary excision, patients should be managed with a vacuum dressing until margins are clear. (3) Definitive reconstruction should be performed by a specialist reconstructive surgeon.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 45 条
  • [1] Final Version of 2009 AJCC Melanoma Staging and Classification
    Balch, Charles M.
    Gershenwald, Jeffrey E.
    Soong, Seng-jaw
    Thompson, John F.
    Atkins, Michael B.
    Byrd, David R.
    Buzaid, Antonio C.
    Cochran, Alistair J.
    Coit, Daniel G.
    Ding, Shouluan
    Eggermont, Alexander M.
    Flaherty, Keith T.
    Gimotty, Phyllis A.
    Kirkwood, John M.
    McMasters, Kelly M.
    Mihm, Martin C., Jr.
    Morton, Donald L.
    Ross, Merrick I.
    Sober, Arthur J.
    Sondak, Vernon K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6199 - 6206
  • [2] Feasibility of Sentinel Node Biopsy in Head and Neck Melanoma Using a Hybrid Radioactive and Fluorescent Tracer
    Brouwer, Oscar R.
    Klop, W. Martin C.
    Buckle, Tessa
    Vermeeren, Lenka
    van den Brekel, Michiel W. M.
    Balm, Alfons J. M.
    Nieweg, Omgo E.
    Olmos, Renato A. Valdes
    van Leeuwen, Fijs W. B.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (06) : 1988 - 1994
  • [3] Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma
    Caraco, C.
    Marone, U.
    Celentano, E.
    Botti, G.
    Mozzillo, N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (09) : 2662 - 2667
  • [4] Regional recurrence after negative sentinel lymph node biopsy for melanoma
    Carlson, Grant W.
    Page, Andrew J.
    Cohen, Cynthia
    Parker, Douglas
    Yaar, Ron
    Li, Anya
    Hestley, Andrea
    Delman, Keith A.
    Murray, Douglas R.
    [J]. ANNALS OF SURGERY, 2008, 248 (03) : 378 - 385
  • [5] Sentinel and nonsentinel node status in stage IB and II melanoma patients: Two-step prognostic indicators of survival
    Cascinelli, Natale
    Bombardieri, Emilio
    Bufalino, Rosaria
    Camerini, Tiziana
    Carbone, Antonino
    Clemente, Claudio
    Lenisa, Leonardo
    Mascheroni, Luigi
    Maurichi, Andrea
    Pennacchioli, Elisabetta
    Patuzzo, Roberto
    Santinami, Mario
    Tragni, Gabrina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4464 - 4471
  • [6] Sentinel lymph node biopsy for head and neck melanomas
    Chao, C
    Wong, SL
    Edwards, MJ
    Ross, MI
    Reintgen, DS
    Noyes, RD
    Stadelmann, WK
    Lentsch, E
    McMasters, KM
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : 21 - 26
  • [7] Single camera imaging system for color and near-infrared fluorescence image guided surgery
    Chen, Zhenyue
    Zhu, Nan
    Pacheco, Shaun
    Wang, Xia
    Liang, Rongguang
    [J]. BIOMEDICAL OPTICS EXPRESS, 2014, 5 (08): : 2791 - 2797
  • [8] Sentinel Node Biopsy for Head and Neck Melanoma: A Systematic Review
    de Rosa, Nicole
    Lyman, Gary H.
    Silbermins, Damian
    Valsecchi, Matias E.
    Pruitt, Scott K.
    Tyler, Douglas M.
    Lee, Walter T.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2011, 145 (03) : 375 - 382
  • [9] Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
    Eggermont, A. M. M.
    Chiarion-Sileni, V.
    Grob, J. -J.
    Dummer, R.
    Wolchok, J. D.
    Schmidt, H.
    Hamid, O.
    Robert, C.
    Ascierto, P. A.
    Richards, J. M.
    Lebbe, C.
    Ferraresi, V.
    Smylie, M.
    Weber, J. S.
    Maio, M.
    Bastholt, L.
    Mortier, L.
    Thomas, L.
    Tahir, S.
    Hauschild, A.
    Hassel, J. C.
    Hodi, F. S.
    Taitt, C.
    de Pril, V.
    de Schaetzen, G.
    Suciu, S.
    Testori, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1845 - 1855
  • [10] Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma
    Erman, Audrey B.
    Collar, Ryan M.
    Griffith, Kent A.
    Lowe, Lori
    Sabel, Michael S.
    Bichakjian, Christopher K.
    Wong, Sandra L.
    McLean, Scott A.
    Rees, Riley S.
    Johnson, Timothy M.
    Bradford, Carol R.
    [J]. CANCER, 2012, 118 (04) : 1040 - 1047